AI assistant
PFIZER INC — Director's Dealing 2022
Mar 1, 2022
29831_dirs_2022-03-01_1781c0c2-a9c6-4324-a592-45d6ff9e64f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2022-02-26
Reporting Person: SUSMAN SALLY (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-26 | Common Stock | M | 63580.0000 | $25.6000 | Acquired | 172880.0000 | Direct |
| 2022-02-26 | Common Stock | F | 18745.0000 | $47.7200 | Disposed | 154135.0000 | Direct |
| 2022-02-26 | Common Stock | F | 29685.0000 | $50.6400 | Disposed | 124450.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-26 | Stock Appreciation Rights | $25.6000 | M | 63580.0000 | Disposed | 2022-02-26 | Common Stock (63580.0000) | Direct |
| 2022-02-28 | Phantom Stock Units | $ | A | 58623.0000 | Acquired | Common Stock (58623.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 747.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3: Price is the closing price of Pfizer common stock on February 25, 2022.
F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F6: Each unit represents one phantom share of common stock.
F7: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon) which have been deferred into the Pfizer Inc. Deferred Compensation Plan.
F8: The units, held under the Deferred Compensation Plan, are paid in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.